Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study).
Increased creatine kinase-MB isoenzymes after coronary stenting are common, and many studies have suggested an association of this increase with an adverse long-term prognosis. How such postprocedural creatine kinase-MB release affects long-term prognosis remains unclear. Whether any actual causal relation exists remains unanswered.
Zairis
Michael N
MN
Department of Cardiology, Tzanio Hospital, Piraeus, Greece.
Ambrose
John A
JA
Ampartzidou
Olga
O
Lyras
Anastassios G
AG
Manousakis
Stavros J
SJ
Makrygiannis
Stamatis S
SS
Beldekos
Demetrios J
DJ
Devoe
Mary C
MC
Fakiolas
Constantine N
CN
Prekates
Athanasios A
AA
Olympios
Christopher D
CD
Argyrakis
Spyros K
SK
Foussas
Stefanos G
SG
D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D016009:Chi-Square Distribution; D003327:Coronary Disease / Q000097:blood* / Q000628:therapy*; D003402:Creatine Kinase / Q000378:metabolism*; D052279:Creatine Kinase, MB Form; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D012044:Regression Analysis; D018709:Statistics, Nonparametric; D015607:Stents
D007527:Isoenzymes; D002097:C-Reactive Protein; D003402:Creatine Kinase; D052279:Creatine Kinase, MB Form